KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	Anti-von Willebrand Factor Nanobody	[1] Von Willebrand factor human	-	-	-	[1] 64
2	Anti-von Willebrand Factor Nanobody, Caplacizumab	[2] Caplacizumab, Von Willebrand factor human	[1] D11160	[1] VWF 💬	[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	[1] 64
3	Anti-von Willebrand Factor Nanobody, INN = Caplacizumab	[2] Caplacizumab, Von Willebrand factor human	[1] D11160	[1] VWF 💬	[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	[1] 64
4	Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)	[2] Caplacizumab, Von Willebrand factor human	[1] D11160	[1] VWF 💬	[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	[1] 64
5	Caplacizumab (an anti-von Willebrand Factor Nanobody)	[2] Caplacizumab, Von Willebrand factor human	[1] D11160	[1] VWF 💬	[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	[1] 64